Juntendo University · Graduate School of Medicine / Faculty of Medicine

Research keywordsretinal diseases・age-related macular degeneration・brolucizumab・intraocular inflammation・polypoidal choroidal vasculopathy・central serous chorioretinopathy・anti-vegf therapy

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Skrypnyk M, Yatsenko T, Riabets O, Salama Y, Skikevych M, Osada T, Tobita M, Takahashi S, Hattori K, Heissig B. Heliyon. 29;10(11):e31777. doi: 10.1016/j.heliyon..e31777. eCollection 5, 2024.2024
• Yatsenko T, Rios R, Nogueira T, Salama Y, Takahashi S, Adachi E, Tabe Y, Hattori N, Osada T, Naito T, Takahashi K, Hattori K, Heissig B. The influence of 4G/5G polymorphism in the plasminogen-activator-inhibitor-1 promoter on COVID-19 severity and endothelial dysfunction. Front. Immunol., Sec. Inflammation, Volume 15 - doi.org/10.3389/fimmu.2024.1445294 30 August, 2024.2024
• Salama Y, Munakata S, Osada T, Takahashi S, Hattori K, Heissig B. Heparin-binding EGF-like growth factor via miR-126 controls tumor formation/growth and the proteolytic niche in murine models of colorectal and colitis-associated cancers. Cell Death & Disease. doi: 10.1038/s41419-024-07126-2, 2024.2024
• Mizoue Y, Ikeda T, Ikegami T, Riabets O, Oishi Y, Tobita M, Akutsu H, Hattori K, Heissig B, Koide K. The stem cell transcription factor ZEP296 transforms NIH3T3 cells and promotes anchorage-independent growth of cancer cells. Int J Dev Biol.67(4):147-153. doi: 10.1387/ijdb.230143hk, 2023.2023

• Official profile